Stockreport

The War Over Cheaper Ozempic Won't End Well for Some Investors [Yahoo! Finance]

Hims & Hers Health, Inc. Class A  (HIMS) 
PDF Shares of Hims & Hers Health, the telehealth provider better known for its trendy commercials for erectile-dysfunction medications, are up more than 150% this year. Th [Read more]